BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15198676)

  • 1. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
    Yu Q; Guo J; Zhou J
    J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations.
    Gao L; Wang J; Wang Y; Andreadis A
    Mol Cell Neurosci; 2007 Jan; 34(1):48-58. PubMed ID: 17137791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.
    Wu JY; Kar A; Kuo D; Yu B; Havlioglu N
    Mol Cell Biol; 2006 Sep; 26(18):6739-47. PubMed ID: 16943417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
    Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
    Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
    Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1.
    Wang Y; Wang J; Gao L; Lafyatis R; Stamm S; Andreadis A
    J Biol Chem; 2005 Apr; 280(14):14230-9. PubMed ID: 15695522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors.
    Hartmann AM; Rujescu D; Giannakouros T; Nikolakaki E; Goedert M; Mandelkow EM; Gao QS; Andreadis A; Stamm S
    Mol Cell Neurosci; 2001 Jul; 18(1):80-90. PubMed ID: 11461155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
    Zhou J; Yu Q; Zou T
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
    Jumaa H; Nielsen PJ
    EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
    Wang Y; Gao L; Tse SW; Andreadis A
    Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.
    Jiang Z; Tang H; Havlioglu N; Zhang X; Stamm S; Yan R; Wu JY
    J Biol Chem; 2003 May; 278(21):18997-9007. PubMed ID: 12649279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of alternative splicing of tau exon 10.
    Qian W; Liu F
    Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kalbfuss B; Mabon SA; Misteli T
    J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.
    Kar A; Havlioglu N; Tarn WY; Wu JY
    J Biol Chem; 2006 Aug; 281(34):24479-88. PubMed ID: 16777844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA.
    Stoilov P; Daoud R; Nayler O; Stamm S
    Hum Mol Genet; 2004 Mar; 13(5):509-24. PubMed ID: 14709600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.